Navigation Links
Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case
Date:2/28/2012

WASHINGTON, Feb. 28, 2012 /PRNewswire-USNewswire/ -- This week the Genetics Policy Institute  (GPI) joined the Coalition for Advancement of Medical Research (CAMR) in filing an amicus curiae ("friend of the court") brief in the United States Court of Appeals for the District of Columbia Circuit, supporting federal funding for human embryonic stem cell research.

GPI previously filed amicus briefs in the United States District Court and in the Court of Appeals, the latter in collaboration with CAMR and the State of Wisconsin. Both earlier briefs focused on the preliminary injunction in the case.

Bernard Siegel, GPI's executive director, stated, "Our brief supports the District Court's ruling on behalf of the government upholding federal funding for human embryonic stem cell research. We make clear that the NIH complied with the Administrative Procedures Act in adopting stem cell research rules. The brief also focused upon arguments relating to statutory interpretation of the Dickey-Wicker Amendment, maintaining that the government has a complete right to fund research on ethically derived stem cell lines."
 
Siegel continued, "We are grateful to GPI's counsel, Neal Goldfarb of the law firm of Butzel Long Tighe Patton, PLLC in Washington, D.C. for his continuing contributions in drafting key arguments in the brief." The amicus brief is available at the GPI web site at www.genpol.org.

GPI's mission is to promote and defend stem cell research and its application in medicine to develop therapeutics and cures for many otherwise intractable diseases and disorders. GPI pursues this mission through production of its flagship annual World Stem Cell Summit, publication of the World Stem Cell Report, special projects, speaking engagements, online newsletters and strategic collaborations. Among its initiatives, GPI maintains the Stem Cell Action Coalition, an alliance of 75 independent organizations, including patient groups, academic institutes, medical philanthropies and science and medical societies, all supporting stem cell research targeting cures.


'/>"/>
SOURCE Genetics Policy Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs
2. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
3. Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
4. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
5. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
6. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
7. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2008 Financial Results
8. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
9. Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
10. deCODE genetics Announces Third Quarter 2008 Financial Results
11. TorreyPines Therapeutics Sells Alzheimers Disease Genetics Program to Eisai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, Sequencing.com will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/29/2017)... CHICAGO , March 29, 2017  higi, the ... ecosystem in North America , today ... Partners and the acquisition of EveryMove. The new investment ... extensive set of tools to transform population health activities ... and lifestyle data. higi collects and secures ...
Breaking Biology News(10 mins):